Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study

Muhammad Ali Ibrahim Kazi, Syed Musa Mufarrih, Akanksha Sirohi, Fahad Hasan, Akshay Sharma, Sanmeet Singh, Nargiz Muganlinskaya, Nowreen Haq · 2026

Read Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study by Muhammad Ali Ibrahim Kazi, Syed Musa Mufarrih, Akanksha Sirohi, Fahad Hasan, Akshay Sharma, Sanmeet Singh, Nargiz Muganlinskaya, Nowreen Haq (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358659.txt.

Description

Muhammad Ali Ibrahim Kazi leads a team of eight studying heart outcomes in people who live with both inflammatory bowel disease and type 2 diabetes, in PLOS ONE in 2026. The pairing is dangerous, since gut inflammation and blood sugar problems feed each other's damage to blood vessels. The authors asked whether modern diabetes drugs in the GLP-1 family are linked to fewer heart events in this high risk group.

Using a large international health records network, they matched over sixteen thousand treated patients with similar untreated ones. Treated patients showed lower rates across the board: heart attack, heart failure, stroke, dangerous rhythms, and blood clots in veins and lungs. The authors caution that records based comparisons show association, not proof of cause, and that the study cannot separate the two drug types it pooled together.

Catalog record

CREATORMuhammad Ali Ibrahim Kazi, Syed Musa Mufarrih, Akanksha Sirohi, Fahad Hasan, Akshay Sharma, Sanmeet Singh, Nargiz Muganlinskaya, Nowreen Haq
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31527
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0358659

Browse the full library · About the Tower of Babel